Laboratory assessment of a gravity-fed ultrafiltration water treatment device designed for household use in low-income settings. by Clasen, Thomas et al.
Am. J. Trop. Med. Hyg., 80(5), 2009, pp. 819–823
Copyright © 2009 by The American Society of Tropical Medicine and Hygiene
819
* Address correspondence to Thomas Clasen, Disease Control and 
Vector Biology Unit, Department of Infectious and Tropical Diseases, 
London School of Hygiene and Tropical Medicine, Keppel St., London 
WC1E 7HT, UK. E-mail:  thomas.clasen@lshtm.ac.uk 
 Laboratory Assessment of a Gravity-Fed Ultrafiltration Water Treatment 
Device Designed for Household Use in Low-Income Settings 
 Thomas  Clasen , * Jaime  Naranjo ,  Daniel  Frauchiger , and  Charles  Gerba 
 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England; 
Department of Soil, Water and Environmental Science, University of Arizona, Tucson, Arizona; and 
Vestergaard Frandsen S.A., Lausanne, Switzerland 
 Abstract.  Interventions to improve water quality, particularly when deployed at the household level, are an effective 
means of preventing endemic diarrheal disease, a leading cause of mortality and morbidity in the developing world. We 
assessed the microbiologic performance of a novel water treatment device designed for household use in low-income 
settings. The device employs a backwashable hollow fiber ultrafiltration cartridge and is designed to mechanically remove 
enteric pathogenic bacteria, viruses, and protozoan cysts from drinking water without water pressure or electric power. In 
laboratory testing through 20,000 L (~110% of design life) at moderate turbidity (15 nephelometric turbidity unit [NTU] ), 
the device achieved log 10 reduction values of 6.9 for  Escherichia coli , 4.7 for MS2 coliphage (proxy for enteric pathogenic 
viruses), and 3.6 for  Cryptosporidium oocysts, thus exceeding levels established for microbiological water purifiers. With 
 periodic cleaning and backwashing, the device produced treated water at an average rate of 143 mL/min (8.6 L/hour) 
(range 293 to 80 mL/min) over the course of the evaluation. If these results are validated in field trials, the deployment 
of the unit on a wide scale among vulnerable populations may make an important contribution to public health efforts to 
control intractable waterborne diseases. 
 INTRODUCTION 
 Unsafe drinking water is a leading cause of preventable dis-
ease, particularly among young children in developing coun-
tries. 1 Waterborne pathogens, including a variety of viral, 
bacterial, and protozoan agents, account for much of the esti-
mated 4 billion cases and 1.8 million deaths from endemic 
diarrheal disease each year. 2 Among children < 5 years of age 
in developing countries, diarrheal disease accounts for 17% 
of all deaths. 2 Microbiologically contaminated water also 
contributes to the heavy burden of disease associated with 
cholera, typhoid, paratyphoid, hepatitis, poliomyelitis, and 
gastroenteritis. Low-income populations are particularly at 
risk of such diseases because of the unavailability of safe water 
and sanitation. 3 
 Interventions to treat and maintain the microbiological 
quality of water at the household level are a promising alter-
native for households without access to a reliable supply of 
safe drinking water. In many settings, both rural and urban, 
household-based water treatment has been shown to be more 
effective in reducing endemic diarrhea than conventional 
treatment at the source or point of distribution. 4,5 Among 
household-based water treatment interventions, filters have 
been shown to be particularly protective against diarrheal dis-
ease. 5 Household-based water treatment has also been shown 
to be highly cost-effective. 6 
 Reaching vulnerable populations at scale with an effective, 
low-cost, long-lasting, and otherwise suitable water treatment 
device has been particularly challenging. 7 Although promoters 
of chlorination, filtration, solar disinfection, and flocculation/
disinfection reported increased coverage and uptake of house-
hold water treatment among low-income populations by 26% in 
2006 and 2007 to 19 million people, this represents less than 2% 
of the persons without access to improved water supplies. 7,8 It is 
even a smaller portion of those whose water is microbiologically 
safe. 8 Although dozens of products have been developed and 
tested, 9 few meet the microbiologic performance levels for 
reductions in bacteria, viruses, and protozoa established by 
the U.S. Environmental Protection Agency (USEPA) 10 and 
incorporated into National Sanitation Foundation (NSF)/
American National Standards Institute (ANSI ) standards, and 
none of these has secured widespread coverage among low-
income populations. Although some microfilters have been 
embraced over chemical disinfectants because of their capac-
ity to improve water aesthetics, most such devices also present 
disadvantages, including comparatively high up-front cost, low 
output, limited longevity, and susceptibility to premature clog-
ging and breakage. 
 Vestergaard Fransen S.A. (Lausanne, Switzerland), the main 
producer of pipe filters for the Guinea Worm Eradication 
Initiative and long-lasting insecticide-treated nets (LLINs) 
for malaria prevention, has developed a microbiological water 
purifier known as “LifeStraw Family.” The device is specifi-
cally designed to build on the company’s experience in rap-
idly scaling up the production and distribution of personal and 
household-based environmental health interventions among 
vulnerable, low-income populations. This work reports on lab-
oratory testing of the microbiologic effectiveness, flow rate, 
and longevity of this new treatment unit. 
 THE WATER TREATMENT SYSTEM 
 The LifeStraw Family is a fully-integrated, gravity-fed, point-
of-use microbial water treatment system intended for routine 
use in low-income settings. To meet the needs of the most vul-
nerable populations, it was designed to operate without elec-
tricity or other power and without a piped-in water supply. 
The unit was also designed to treat water of unknown micro-
biologic quality, and thus meet internationally recognized lev-
els for microbiological water purifiers. It was also designed to 
operate under heavier levels of turbidity that may characterize 
water in such settings, especially during rainy seasons. 
 The microbiologic barrier consists of a 26-cm-long × 3-cm-
diameter plastic cylindrical cartridge containing a number of 
hollow fibers with a 20-nm pore size. Although the cartridge is 
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potentially suitable for tabletop and other configurations, we 
tested a configuration designed for mass distribution and use 
in settings that do not necessarily have surfaces for tabletop 
units ( Figure 1 ). Source water is introduced into the system 
by dipping the 2.5 L receptacle into an open vessel or pouring 
water into it if hanging or mounted on a wall. The water passes 
through a cleanable 27-µm textile prefilter mounted inside a 
removal plastic basket inside the receptacle and then through 
a 1 m length of 12-mm-diameter plastic tubing filling the car-
tridge. A slow-eluting solid chlorine tablet can be installed in 
a halogen chamber at the receptacle to help prevent biofilm, 
but was not included in this assessment to avoid any biocidal 
action that might be attributable to the disinfectant. When 
the side tap is opened, water passes through the walls of the 
hollow fiber membrane bundle and out the tap, mechanically 
removing microbes and other suspended solids greater than 
20 nm in size. 
 The prefilter is cleaned by removing the prefilter basket 
from the receptacle and rinsing it in water. The microbial car-
tridge must also be cleaned from time to time by backwashing 
it. This is done by closing off the side tap, squeezing the hand 
pump located on the lower part of the cartridge three times, 
and opening the cock at the bottom of the cartridge for a few 
seconds to allow the backwash to flow to waste. The bottom 
cock is then closed and the unit is ready for use. 
 The unit is designed to produce ~150 mL of product water/
minute (9 L/hour) and to last for at least 18,000 L. As it relies 
on mechanical filtration and not disinfection or adsorption, 
there is no need for a means of measuring volume of water 
treated or end of useful life; as long as the device remains 
intact, water from the tap will be effectively treated. When the 
flow from the unit cannot be restored to an acceptable rate by 
prefilter cleaning and cartridge backwashing, the entire unit 
is intended to be replaced. Assuming a household of five per-
sons, the unit would provide 2 L of drinking water/person/day 
for almost 5 years without any replacement parts. In larger 
quantities, the manufacturer sells this configuration for about 
US$20.00. Using the foregoing assumptions, this works out to 
less than US$1/person/year. The cost per liter treated would 
be US$0.001/L. 
 METHODS AND MATERIALS 
 Setup and test waters.  Test methods were based generally on 
EPA Protocol and Guide Standard for Testing Microbiological 
Water Purifiers (the “EPA Protocol”). 10 Three production units 
of the LifeStraw Family provided by the manufacturer were 
conditioned in accordance with the manufacturer’s instruc-
tions with unspiked test water and installed on the bench for 
testing using apparatus conforming to EPA Protocol ( Figure 1 ). 
Aging was performed using water based on EPA general test 
water #1, except that the turbidity level was increased from 
0.1 to 5.0 NTU prescribed by the Protocol to 15 nephelomet-
ric turbidity unit (NTU), and the organic carbon level was 
increased from 0.1–5.0 mg/L prescribed under the Protocol 
to 5 mg/L. These harsher conditions were intended to chal-
lenge the longevity and flow rate of the device. Microbial chal-
lenges were performed using water based on EPA challenge 
test water #3, except that the water was maintained at room 
temperature and not chilled to 4°C as prescribed by Protocol. 
The performance of occlusion devices, such as the LifeStraw 
Family, is not expected to be impacted by low temperatures, 
which are known to affect halogen disinfection. The param-
eters for the test water, including the materials used for adjust-
ing the parameter, are set forth in  Table 1 . 
 Test organisms.  The test organisms consisted of microbes 
shown to simulate the range of waterborne pathogens com-
monly found in untreated water. The bacteria group was rep-
resented by  Escherichia coli (ATCC # 25922) spiked into the 
input water at concentrations of 10 7 to 10 8 colony forming units 
(CFU)/100 mL. The viral group was represented by male–
specific coliphage  MS2 (ATCC #15597-B-1) spiked into the 
input water at concentrations of 5 × 10 8 plaque forming units 
(PFU)/100 mL and inoculated into  E. coli (ATCC # 15597) for 
assay. The MS2 coliphage has been recognized as a suitable 
surrogate for enteric viruses for water treatment processes 11 
and point-of-use device testing. 12 The protozoan cyst group 
was represented by  Cryptosporidium parvum oocysts spiked 
into the input water at concentrations of 5 × 10 6 /L. 
 Microbiologic methods.  Escherichia coli was grown over-
night in Trypticase Soy broth (Difco, Detroit, MI) at 37°C 
to obtain the organisms in the stationary growth phase. The 
bacterial cells were pelleted by centrifugation and resus-
pended in phosphate buffered saline (PBS). This procedure 
was repeated three times to remove organic matter present in 
the broth. Bacterial assays were conducted by the membrane 
filtration method on m-Endo Agar LES (Becton Dickinson, 
Cockeysville, MD). Appropriate dilutions of influent samples 
were made in sterile 0.025 M PBS at pH 7.0. A 100 mL sample 
of undiluted unit effluent was also assayed. All assays were 
in triplicate according to Standard Methods. 13 The MS-2 virus  Figure 1. Schematic of device. 
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stocks were prepared by growth on the host bacterium and 
purified, as previously, and assayed by the double agar over-
lay method as described earlier. 11  Cryptosporidium parvum 
oocysts were obtained from the feces of infected calves and 
purified by a discontinuous sucrose gradient. 14 The oocysts 
were exposed to an ultraviolet (UV)-C light (40 mµWsec/
cm 2 blub) for one hour to inactivate the oocysts to reduce risk 
of infection during conduct of the tests. Samples of influent 
(10 mL) and effluent (100 mL) were centrifuged at 400 × g for 
15 minutes to pellet the oocysts. After resuspension of the pel-
let in PBS, the oocysts were counted using a Sotlite hemocy-
tometer (Baxter Healthcare Corp., McGraw Park, IL), with a 
phase contrast microscope at 400× magnification. 
 Water spiking and sampling.  Each unit was filled automati-
cally with specified test water when the raw water reservoir 
reached the refill level specified by the manufacturer. Units 
were tested in a 16-hour cycle (i.e., minimum of 8 hours off per 
day) over ~330 days during which the units produced 20,000 L 
representing roughly 110% of their 18,000 L design life. 
Effluent was sampled from the tap of each test unit in accor-
dance with the schedule prescribed by the EPA Protocol. 
This requires sampling at prescribed percentages of the prod-
uct’s design life. Throughout the test period, average turbidity 
and bacteria levels were maintained continuously at the pre-
scribed levels. The MS2 virus was spiked into the challenge 
water at the prescribed concentrations for one complete cycle 
immediately preceding the taking of a sample and for one 
complete cycle during the taking of a sample. 
 Cleaning.  In accordance with the manufacturer’s instruc-
tions and the testing protocol, cleaning of the pre-filter and 
backwashing of the filter was performed whenever the flow 
rate fell below 80 mL/minute. For cleaning, the pre-filter was 
removed from the raw water reservoir and rinsed by hand in 
tap water. The filter was cleaned by closing the treated water 
tap, squeezing the ballcock three times, opening the backwash 
water tap to let the backwash water flow to waste during a few 
seconds, and closing the backwash water tap. Once each week 
during testing, the raw water reservoir was also cleaned with a 
soft brush or a cloth and rinsed with tap water. 
 Monitoring and assessment.  Quality assurance testing was 
conducted for the seed organisms under environmental con-
ditions at the beginning and end of each test day to ensure 
that there was no significant change over the test day. This 
was done by measuring populations as dispersed by the sup-
ply tank at the beginning and end of the 16-hour test day to 
detect possible incidental effects, such as proliferation, die-off, 
adsorption to surfaces, etc. The log reduction value (LRV) for 
each test organism or proxy was determined as follows:
LRV = log10(Cf) - log10(Cp), 
where Cf is the feed concentration of the challenge organism 
or proxy and Cp is the filtrate concentration of the challenge 
organism or proxy. 
 It is noted that to meet the requirements of a microbio-
logical water purifier under the EPA Protocol, the geometric 
mean of all LRVs must be at least 6 for bacteria, 4 for viruses, 
and 3 for cysts. Moreover, not more than 10% of the influent/
effluent sample pairs may deviate from the required LRV by 
one order of magnitude in the case of bacteria and viruses, and 
one-half order of magnitude in the case of cysts. 
 RESULTS 
 Microbiologic assessment.  Table 2 sets forth the log reduction 
values at each sampling point for each of the three treatment 
units for the bacterial, viral, and protozoan cyst test organisms. 
The mean log 10 reduction for all sample pairs over the life of 
the test protocol was 6.9 for  E. coli , 4.7 for  MS2 , and 3.6 for the 
 C. parvum oocysts. At each sampling point, all three treatment 
units succeeded in reducing  E. coli by at least 4.8 logs, MS2 by at 
least 3.6 logs, and  Cryptosporidium oocysts by at least 3.1 logs. 
 Flow rate and cleaning.  Figure 2 shows the effluent flow rate 
of mL/minute for each unit tested over 20,000 L (111% of the 
18,000 L design life). Although the initial flow rates ranged 
from 200–293 mL/minute, the rate fell to 129–143 mL/minute 
by 25% of life (3,750 L), and to 100–130 mL/minute by 100% 
of life (18,000 L). Thereafter, flow rates diminished to 60–110 
L/minute. Over the 18,000 L design life, the mean flow rates 
ranged from 132 mL/minute to 159 mL/minute, with an over-
all mean of 146 mL/minute (8.8 L/hour). The average required 
interval for cleaning to restore flow rate was 11 hours of oper-
ation for the filter cartridge and 30 hours for the prefilter. 
 Filter life.  In accordance with the terms of the study 
protocol, the device was tested through 20,000 L, representing 
111% of its design life. Although flow rates showed some evi-
dence of diminishing over filter life, all three units continued 
to produce at least 100 mL/min through the 18,000 L design 
life. There was no evidence of impaired microbiologic perfor-
mance through 20,000 L of operation. 
 DISCUSSION 
 Results from this assessment indicate that the treatment 
unit is effective under controlled circumstances in removing a 
range of microbial indicators of fecal contamination for up to 
20,000 L, or roughly 110% of its design capacity. The average 
log 10 reductions exceeded 6 logs (99.9999%) of the test organ-
ism for bacteria, 4 (99.99%) of the test organism for virus, 
and 3 logs (99.9%) of the test organism for protozoan cysts. 
 Table 1
Test water parameters* 
Parameter Aging water Challenge water Material for adjusting test water characteristics
pH 7.5 ± 0.25 9.0 ± 0.20 NaHCO3
Total organic carbon (TOC) 5.0 mg/L† 10 mg/L Humic acid
Turbidity 15 ± 1 NTU† 100 NTU ISO 12103-1, A2 fine test dust 
(Power Technology , Burnsville, MN)
Temperature 20°C ± 0.5°C 20°C ± 0.5°C‡
Total dissolved solids 480 mg/L 15,000 mg/L Sea salts, Sigma S9883 or equivalent
Disinfectant residue No detectible disinfectant No detectible disinfectant Granular activated charcoal filter
Bacteria/virus/cyst No detectable CFU/100 mL or PFU/L Challenge level Refer to test organisms
 *  CFU = colony forming unit; PFU = plaque forming unit. 
 †  EPA general test water #1 prescribes turbidity of 0.1–5.0 NTU and TOC of 0.1–5.0 mg/L. 
 ‡  EPA challenge test water #3 prescribes a temperature of 4°C ± 0.5°C. 
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These LRVs would meet the requirements for a microbial 
water purifier prescribed by the EPA Protocol. 
 The treatment unit continued to produce 100–130 mL of 
water/minute through 18,000 L, despite increasing the tur-
bidity of the aging water to 15 NTU (150 times the minimum 
level prescribed by the EPA Protocol) and increasing the total 
organic carbon level to 5.0 mg/L (50 times the minimum). This 
is less than the 150 mL/minute design rate, but significantly 
greater than the flow rate from ceramic filters, which are also 
used in low-income settings. Cleaning was required, but at fre-
quencies that probably would not exceed once per week under 
real world conditions. 
 In accordance with the study protocol, testing of the units 
was terminated after 20,000 L, representing 111% of design 
life. At this point, there was no evidence of any failure or dim-
inution of microbiologic performance or flow rate. As the 
device relies solely on mechanical filtration to remove micro-
bial pathogens from the water, its microbiologic performance 
should not be impaired by continued use past such levels 
unless there is a fracture or other failure in the seal that holds 
the hollow fibers in place. Further testing in the field will help 
determine the actual longevity of the device and the need for 
a halogen to control biofilm, which may build up on the hollow 
fibers over long-term use. 
 This device is one of the few point-of-use water treatment 
options designed for routine use in low-income populations 
that meets the 6-4-3 standard for microbiological water purifi-
ers. Hybrid filters that combine filtration/adsorption with dis-
infection have been shown to meet the 6-4-3 standard, 7,9 but 
these are not fully serviceable in the field and require replace-
ment of consumable components. Sachets combining a floc-
culant and a disinfectant also have been shown to meet the 
6-4-3 standard, 15 but requires batch treatment of a consumable 
product. Other common point-of-use water treatment prod-
ucts meet this international standard for bacteria, viruses, or 
cysts, but not all three. 7,9 
 Our results must be interpreted in the context of certain 
limitations. First, this assessment was undertaken under con-
trolled laboratory conditions, not in the field and not as the 
unit may actually be used by householders. Second, this evalu-
ation was undertaken using a single aging and challenge water. 
Although these waters were specifically designed to reflect 
the key parameters that would challenge filtration devices 
(and actually exceeded the EPA guidelines for turbidity and 
TOC), the performance and life of water treatment units can 
be affected by various chemical and physical conditions that 
may not be encompassed by these tests. Finally, the 20,000 L 
evaluation reported here was conducted over just 10 months, 
less than a quarter of the time a householder might actually be 
expected to use the device in the field. It is possible that use 
of the device over longer periods in the tropics could accel-
erate the growth of biofilm on the hollow fiber membranes 
and thus impair flow rate or cause premature choking. The 
manufacturer reports that it has developed a slow-eluting 
chlorine donor that can be permanently deployed in the unit 
under the prefilter if field testing shows evidence of adverse 
impacts because of biofilm. However, this chlorine donor was 
not incorporated into the units we tested. 
 We note that as the treatment unit has no residual dis-
infection, the treated water is immediately susceptible to 
recontamination, a particular problem in the low-income 
settings for which it was designed. 16 Although the manufac-
turer has designed an alternative configuration that includes a 
collapsible or rigid container to improve the safe storage of 
treated water, this will add to the cost. Field testing is under-
way to investigate the extent to which such recontamination 
actually occurs when the devices are used by a target 
population. 
 Notwithstanding these limitations, this study does establish 
the basis for further testing in the field. Such testing is neces-
sary to confirm the durability of the system and to identify any 
potential gaps in performance under actual field conditions. 
 Table 2
Summary of log reduction values (LRVs) at each sampling point 
Test point
Percentage of design life of unit 0% 25% 45% 50% 60% 80% 100% 110%
Volume passed (L) 10 3,750 7,500 9,000 11,250 15,000 18,000 20,000
Unit 1
 Escherichia coli > 7.1* > 8.3 > 6.9 > 6.9  4.8 > 7.5 > 7.3 > 7.6
MS2  3.8 5.7 4.2  3.8  3.6 4.7 > 6.0 > 6.8
 Cryptosporidium oocysts > 3.1 3.8 3.4 3.7 3.9 > 3.7 > 3.8 > 3.8
Unit 2
 E. coli 6.6 6.3 > 6.9  5.8 6.1 > 7.5 > 7.3 > 7.6
MS2  3.6  3.8  3.5 4.4 4.8 4.7 > 6.0 > 6.8
 Cryptosporidium oocysts > 3.1 > 3.6 3.4 3.4 3.5 > 3.7 > 3.8 > 3.8
Unit 3
 E. coli > 7.1 6.8 > 6.9  5.4 7.0 > 7.5 > 7.3 > 7.6
MS2  3.6  3.7  3.6 4.4 4.3 5.0 > 6.0 > 6.8
 Cryptosporidium oocysts > 3.1 > 3.6 3.6 3.2 3.9 > 3.7 > 3.8 > 3.8
 *  Log 10 reduction. Figures in italics are individual sampling points where the LRV was below the 6-4-3 average for bacteria, viruses, and cysts, respectively, under the EPA Guide Standard. 
 Figure 2. Flow rate (mL/minute) of tested units over 20,000 L. 
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It is also important to assess the performance and life of the 
treatment unit under a wider variety of water conditions and 
when subjected to less than optimal maintenance. 
 The ultimate objective of water treatment units such as this, 
however, is not only to improve water quality but to improve 
human health. The increasing body of evidence suggesting 
the potential for household water treatment to dramatically 
reduce diarrheal morbidity provides good reason to believe 
that the device can also prevent disease. If this turns out to be 
the case, then a company that has demonstrated success in the 
widespread distribution of environmental health products to 
low-income populations should be encouraged to scale up the 
intervention on an affordable and sustainable basis. 
 Received September 22, 2008.  Accepted for publication December 
14, 2008. 
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